Vanda Pharmaceuticals
VNDA
#7541
Rank
ยฃ0.29 B
Marketcap
ยฃ5.04
Share price
1.20%
Change (1 day)
36.12%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ30.38 Million a decrease over its 2023 earnings that were of -ยฃ10.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million200.42%
2024 -ยฃ30.38 Million191.43%
2023 -ยฃ10.43 Million-320.45%
2022 ยฃ4.72 M-84.99%
2021 ยฃ31.5 M54.8%
2020 ยฃ20.34 M19.42%
2019 ยฃ17.04 M4.93%
2018 ยฃ16.24 M-228.6%
2017 -ยฃ12.63 Million-8.98%
2016 -ยฃ13.88 Million-53.79%
2015 -ยฃ30.03 Million-30.18%
2014 -ยฃ43 Million173.08%
2013 -ยฃ15.75 Million-25.33%
2012 -ยฃ21.09 Million163.61%
2011 -ยฃ8 Million-221.15%
2010 ยฃ6.6 M-124.53%
2009 -ยฃ26.92 Million-29.44%
2008 -ยฃ38.15 Million-36.2%
2007 -ยฃ59.8 Million21.81%
2006 -ยฃ49.09 Million170.55%
2005 -ยฃ18.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ12.26 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ16.81 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.20 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.00 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.85 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.1 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.25 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA